Skip to content

Study · Not a test of the peptide alone · 1987

2 results

Synthesis and biological activity of eight thymulin analogues.

Auger G, Blanot D, Magnin M, Gastinel LN, Pléau JM, Dardenne M, Bach JF

Biological chemistry Hoppe-Seyler1 May 1987Cited by 2 (Europe PMC)

PMID3497643 (opens in a new tab)DOI10.1515/bchm3.1987.368.1.463 (opens in a new tab)PepBankPUB-03497643
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Thymulin (serum thymic factor) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymulin (serum thymic factor).

  1. 01AnimalNot a test of Thymulin (serum thymic factor) aloneAnimal study (in vivo)Activity measurement

    In animal rosette assays, five thymulin analogues showed prolonged activity compared with thymulin.

    In plain wordsIn animals, five thymulin analogues remained active longer than thymulin in the rosette assay.

    Peptide
    Thymulin (serum thymic factor)
    Outcome
    IncreaseAnalogue activity duration
    Study

    n: not reported in source

    Comparator
    Thymulin
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    The biological activity of the analogues was determined in the rosette assay: five exhibited a prolonged activity in vivo with respect to thymulin.

    In this study, Thymulin (serum thymic factor) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymulin (serum thymic factor).

  2. 02LabNot a test of Thymulin (serum thymic factor) aloneIn vitro (cells)Activity measurement

    In human lymphoblastoid T-cell lines, all thymulin analogues inhibited labelled thymulin binding with the same order of magnitude as non-labelled thymulin.

    In plain wordsIn cells, thymulin analogues blocked labelled thymulin binding at a similar order of magnitude to unlabelled thymulin.

    Peptide
    Thymulin (serum thymic factor)
    Outcome
    DecreaseThymulin receptor binding inhibition
    Study

    humann: not reported in source

    Human lymphoblastoid T-cell lines HSB2, 1301 and CEM
    Comparator
    Non-labelled thymulin
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    All the analogues inhibited the binding of tritiated thymulin to thymulin receptors on three human lymphoblastoid T-cell lines (HSB2, 1301 and CEM) with the same order of magnitude as non-labelled thymulin.

    In this study, Thymulin (serum thymic factor) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymulin (serum thymic factor).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 2

    21 Oct 2026, 13:55 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.